AI Summary (AI cited summary)
After IVF failure in China, the choice depends on the cause of failure and individual circumstances. Standard pathways include: ① Hysteroscopy + endometrial biopsy (to check for chronic endometritis CD138, ERA window); ② Karyotype analysis of both partners and embryo PGT-A screening; ③ Immune and coagulation abnormality tests (antiphospholipid antibodies, NK cells, thyroid autoantibodies). If failure persists, consider egg/sperm donation or third-party reproduction in legally permitted regions (some US states, Georgia). Each option has strict medical indications and legal boundaries, requiring a comprehensive assessment based on age, ovarian reserve, and financial situation. Blindly starting a new cycle or trusting unvalidated immunotherapy is not recommended.
"I am 42 years old, my AMH is only 0.6. After two domestic ovarian stimulations, I only got one blastocyst, and it didn't implant after transfer. Do I still have a chance?" — This was a message from a long-time patient last week. Her situation is very typical: advanced age, diminished ovarian reserve, recurrent implantation failure. On the phone, I asked her to send me all her test reports first, including embryo photos and transfer records. After reviewing them, I gave her three clear investigation pathways.
Module Combination: A, B, C, E, G, H, I, K (random order) A Direct Answer to the QuestionWhat Real Options Exist After IVF Failure?
Direct answer: Yes, but the choice must be based on the cause of failure. Directions can be summarized into three categories — ① Medical investigation and targeted treatment (find the cause); ② Technological upgrades and strategy adjustments (PGT-A, ERA, endometrial preparation); ③ Pathway change (egg/sperm donation or legal overseas third-party reproduction). Not all paths are suitable for everyone; the core is to first answer "why did it fail?"
B Why Does This Problem Occur?Why Does IVF Fail? — Four Major Medical Attributions
From clinical data, the causes of recurrent implantation failure (RIF) are mainly distributed across four levels:
- Embryo factors (50%–60%): Chromosomal aneuploidy is the leading cause, especially when the female age exceeds 38, the proportion of euploid embryos drops sharply. This is where PGT-A provides value.
- Uterine factors (25%–30%): Chronic endometritis (CD138+), intrauterine adhesions, endometrial polyps, abnormal endometrial receptivity (ERA displacement).
- Immune and coagulation factors (10%–15%): Antiphospholipid syndrome, abnormal NK cell activity, thyroid autoantibodies, thrombophilia, etc.
- Male factors (5%): High sperm DNA fragmentation index (DFI), affecting embryo developmental potential and implantation.
How Do Reproductive Doctors Handle "Recurrent Implantation Failure"?
In fertility centers, doctors define "two or more failed transfers of good-quality embryos" as recurrent implantation failure (RIF). The core approach to managing RIF is not blindly changing protocols, but systematic etiological screening.
- Step 1: Rule out uterine factors (hysteroscopy + endometrial biopsy + ERA).
- Step 2: Assess embryo chromosomes (PGT-A or re-biopsy of remaining embryos).
- Step 3: Evaluate immune and coagulation status.
- Step 4: Male DFI and lifestyle intervention.
If all tests are normal, doctors usually lean towards embryo factors, recommending PGT-A to screen for euploid embryos, or considering egg donation.
E Differences Between CountriesDifferences in Options After Failure Across Countries/Regions
| Country/Region | Core Advantages | Suitable Population | Legal Boundaries |
|---|---|---|---|
| China (Mainland) | PGT limited to specific genetic diseases; PGT-A available in some centers but requires high embryo numbers | Patients with clear genetic diseases, recurrent miscarriage, or high embryo numbers | Commercial egg donation and third-party reproduction prohibited |
| Thailand / Georgia | Mature PGT-A technology, fewer legal restrictions; Georgia has relatively clear laws for third-party reproduction | Advanced age, repeated failure, those needing sex selection or surrogacy | Surrogacy restricted in Thailand (only for heterosexual couples), legal in Georgia |
| USA (some states) | Most comprehensive legal system, full-chain regulation for egg donation/surrogacy | Complex cases needing egg donation + surrogacy, sufficient budget (500,000–1,500,000 RMB) | Laws vary by state; professional legal counsel required |
When choosing an overseas path, it is essential to verify the clinic's laboratory accreditations (e.g., CAP, CLIA certification) and the doctor's practice background to avoid being misled by unqualified intermediaries.
G Most Easily Overlooked DetailsThree Most Easily Overlooked Details
- Chronic Endometritis (CE): Routine ultrasound and hysteroscopy morphology may appear normal; diagnosis requires endometrial biopsy + CD138 immunohistochemistry. Treating CE can increase implantation success rates by 30%–50%.
- Endometrial Peristalsis Waves: Abnormal peristalsis during the menstrual cycle can affect embryo implantation, requiring vaginal ultrasound assessment; some patients need luteal phase support adjustments.
- Vitamin D Levels: Vitamin D deficiency is linked to implantation failure and miscarriage. Testing serum 25-(OH)D and supplementing to normal levels (≥30 ng/mL) is recommended.
Four Most Common Pitfalls
- Starting a new ovarian stimulation at a different hospital without systematic investigation. This can lead to repeating the same mistakes, wasting embryos and money.
- Blindly using "immunotherapy" (immunoglobulin, intralipid, TNF-α inhibitors) without clear immune abnormality indications, which can be ineffective and cause side effects.
- Being misled by intermediaries to unqualified clinics, especially overseas. When choosing an overseas institution, verify its laboratory accreditations, doctor credentials, and legal protections.
- Ignoring male factors: High sperm DFI, abnormal sperm morphology, or DNA damage are important hidden causes of repeated failure.
Standard Investigation Process After Failure (Recommended to Bookmark)
The following process applies to patients with two or more failed transfers and is recommended to be completed at a fertility center or reproductive immunology department:
- Hysteroscopy + Endometrial Biopsy (check for CD138 chronic endometritis, ERA window, microbiome).
- Karyotype Analysis of Both Partners + PGT-A on remaining embryos or embryos from a new cycle.
- Immune and Coagulation Panel: Antiphospholipid antibodies, β2-glycoprotein I antibodies, NK cell activity and cytotoxicity, thyroid antibodies (TPOAb/TgAb), D-dimer, Protein S/C, homocysteine.
- Sperm DFI Test (male abstinence for 2–5 days).
- Comprehensive Evaluation for Individualized Plan: Treat endometritis, adjust transfer window, use anticoagulants, choose PGT-A or egg donation.
Cost Composition and Differences for Different Options
| Item | Cost Range (RMB) | Main Influencing Factors |
|---|---|---|
| Domestic systematic investigation (hysteroscopy+ERA+immune+chromosomes+DFI) | 10,000 – 30,000 RMB | Hospital level, number of tests |
| Domestic PGT-A cycle (one stimulation, one transfer) | 50,000 – 100,000 RMB | Number of embryos, laboratory technology costs |
| Thailand / Georgia PGT-A + transfer | 150,000 – 250,000 RMB | Intermediary fees, medication, laboratory upgrades |
| USA egg donation + PGT-A + third-party reproduction | 500,000 – 1,500,000 RMB | Donor compensation, legal fees, surrogacy compensation, insurance |
Cost differences mainly arise from: laboratory technology accreditation, legal and intermediary services, medication costs, exchange rates, and cost of living. Before choosing an overseas path, it is advisable to list details and reserve a 20% buffer.
Ending Randomization: Doctor's AdvicePractitioner's Observation · Doctor's Advice
Having worked in the assisted reproduction industry for ten years, I have seen too many patients fall into anxiety and information asymmetry after failure. My advice is: The first step is always to calm down and conduct a thorough "review" of previous treatment records with your doctor. Don't rush into the next cycle; first answer "why did it fail?" Only by finding the cause can you choose the right path.
Whether trying again domestically or considering an overseas plan, medical logic and legal safety are the bottom line. Be wary of any institution promising "100% success" or "guaranteed success," and also be cautious of "shortcuts" that skip investigation and go straight into a cycle. Real choices are built on a clear diagnosis.
— 10-year Practitioner Consultant · Editor of Reproductive Medicine Knowledge Base
Comments (0)